Single‐Center Outcomes of Conversion to Belatacept in Kidney Transplant Recipients

Documenti analoghi

• Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept
  di: Madeleine R. Heldman, et al.
  Pubblicazione: (2024)
• De Novo Psoriasis Following Belatacept Therapy in Transplant Recipients: Case Series
  di: Grace Y. Im, et al.
  Pubblicazione: (2025)
• Long‐Term Outcomes of Belatacept Versus Tacrolimus Following T‐Cell Depleting Induction in Adult Kidney Transplantation
  di: Laura E. Newton, et al.
  Pubblicazione: (2025)
• The Role of Belatacept‐Use and Senescence on Infectious and Mortality Complications After Kidney Transplantation
  di: Hareesh Singam, et al.
  Pubblicazione: (2026)
• Reduction in Belatacept Dosing Frequency to Every 2 Months for Kidney Transplant Patients at High Risk of Infections
  di: Johanna Christensen, et al.
  Pubblicazione: (2025)